Partial and radical nephrectomy for T3a RCC have similar 5-year rates of overall and cancer-specific survival, according to a propensity score-matched analysis. WASHINGTON, DC—Partial nephrectomy (PN) ...

Please provide your email address to receive an email when new articles are posted on . Lower rates of adverse outcomes were linked to higher technical skill Surgeons with higher scores had lower ...

PN and RFA offer similar survival for cT1a RCC tumors ≤2 cm, but PN is superior for larger tumors. RFA may be considered for elderly patients with comorbidities, especially for tumors ≤2 cm. PN ...

Immune checkpoint inhibitors in the peri-operative setting in renal cell carcinoma: A meta-analysis of the randomized clinical trials. Cabozantinib in combination with atezolizumab in non-clear cell ...

Results are from a single arm phase 2 clinical trial of patients with complex clear cell RCC. Neoadjuvant axitinib may enable patients with certain complex renal tumors to undergo partial nephrectomy ...

Microbubble ultrasound compared to dynamic contrast MRI and CT for the assessment of vascular response to sunitinib in renal cell carcinoma. Background: Data are scarce on literature describing ...

An international study examined outcomes between a single-port (SP) versus a multi-port (MP) approach to RAPN, with a focus on elderly patients. Despite similar demographics among patients ≤64 years ...

Stage 2 kidney cancer involves a tumor over 7 cm, confined to the kidney, often treated surgically. Diagnosis includes imaging, blood tests, and possibly biopsy to confirm cancer type and stage.

LOUISVILLE, Ky. -- Minimally invasive ablative therapy for early kidney cancer had an increased risk of local and metastatic recurrence, which is associated with increased mortality, Swedish ...